Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Solid Tumor × ulixertinib × 90 days × Clear all

Sponsor

Conditions

Glioma 2 Colorectal Neoplasms 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Melanoma 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Histiocytosis, Langerhans-Cell 1 Histiocytic Sarcoma 1 Hepatoblastoma 1 Head and Neck Neoplasms 1 Glioblastoma 1 Esophageal Neoplasms 1 Ependymoma 1 Cholangiocarcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

tislelizumab 6 Injections 6 pembrolizumab 3 Nivolumab 3 toripalimab 2 Bevacizumab 2 zimberelimab 1 olaparib 1 erdafitinib 1 durvalumab 1 cemiplimab 1 avelumab 1 atezolizumab 1 Paclitaxel 1 Oxaliplatin 1 Leucovorin 1 Fluorouracil 1 Drug Therapy 1 CD3 Complex 1 BID protein, human 1 Appointments and Schedules 1 Antineoplastic Agents 1 APG-1387 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡